Hepatocellular carcinoma (HCC) is one of the most common malignancies with poor prognosis. It causes nearly 1 million deaths annually worldwide. But only a minority of patients is eligible for surgical therapies due to advanced tumors or extrahepatic diseases at primary diagnosis. Recently, the methods of gene delivery are gradually developing and have made great progresses. So the gene therapy of HCC is a hot spot of the biology and clinic medical currently. Suicide gene therapy can be envisioned as a powe...
| 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
